Skip to content

Evaluation of sesame (Sesamum indicum) effects on some biochemical parameters in type 2 diabetic patients

Evaluation of sesame (Sesamum indicum) effects on some biochemical parameters in type 2 diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105161640N4
Enrollment
50
Registered
2011-11-27
Start date
2011-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Tahini (sesame)- 2 table spoon with bread in breakfast for 6 weeks. Intervention 2: 2 slices bread with cheese in breakfast for 6 weeks.
Treatment - Other
Tahini (sesame)- 2 table spoon with bread in breakfast for 6 weeks
2 slices bread with cheese in breakfast for 6 weeks

Sponsors

Research Institute for Endocrine Science, Shaheed Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: subjects between 18-60 years old; type 2 diabetic pateints without insulin therapy; pateints with history of diabetes more than one year; pateints with body mass index between 18 to 35 kg/m2. Exclusion criteria: pregnant or lactating women; smokers and alcohol sonsumers; pateints cosume antioxidant supplements (vitamin E and C, caroteniodes and coQ10); pateints with cardiac, hepatic, respiratory and chronic renal diseases; pateints with acute or chronic inflammation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lipid profile. Timepoint: Baseline and 6 weeks after intervention. Method of measurement: Biochemistery analysis.;Blood pressure. Timepoint: Baseline and 6 weeks after intervention. Method of measurement: Monometer.;Oxidative stress. Timepoint: Baseline and 6 weeks after intervention. Method of measurement: Biochemical analysis.;Inflammatory markers. Timepoint: Baseline and 6 weeks after intervention. Method of measurement: Biochemical analysis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Mirmiran

Obesity Research Center, Research Institue for Endocrine Science, Shaheed Beheshti University of Med

mirmiran@endocrine.ac.ir+98 21 2243 2500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026